|Iupac Name||1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy) Benzyl) Benzene|
|Standard||Offered as per in House Specifications|
|Packing||Offered in Export Worthy Packing or as per Our Customer Requirements|
|Supplied By||UMA Brothers, India|
Empagliflozin is new molecule to fight type 2 diabetes. It is good inhibitor of sodium-glucose co-transporter 2 (sglt2; slc5a2) with antihyper glycemic activity. It improves glycemic control in adults with type 2 diabetes mellitus.
It is formulated as coated tablets and film-coated tablets for oral route of administration.
Empagliflozin is a sodium-dependent glucose transporter-2 inhibitor (sglt-2 inhibitor). The drug candidate leads to reductions in hepatic glucose production and amelioration of glucotoxicity.
It Is White Colour Powder With Purity More Than 99% And Have Boiling Point 665 C Degree And Flash Point Is 356 C Degree.